Dave Weiner

Stock Analyst at Piper Sandler

(1.18)
# 1946
Out of 5,372 analysts
8
Total ratings
66.67%
Success rate
8.75%
Average return
2 Stocks
Name Action PT Current % Upside Ratings Updated
MYGN Myriad Genetics
Maintains: Overweight
13 9
5.08 77.17% 3 May 15, 2025
LULU Lululemon Athletica
Upgrades: Buy
58 0
n/a n/a 5 Dec 14, 2017